8-K/A XBRL

FORM 8-K/A

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: January 27, 2023
Period of Report: January 23, 2023
Accession Number: 0001104659-23-007585

View Document ↗ View on SEC.gov ↗